Hampton Financial Corporation Announces Results of Annual Meeting of Shareholders
Globenewswire· 2026-02-25 22:44
Core Insights - Hampton Financial Corporation announced the results of its Annual Meeting of Shareholders held on February 25, 2026, where all matters proposed in the management information circular dated January 27, 2026, were approved, including the election of six incumbent directors [1] Company Overview - Hampton Financial Corporation is a private equity firm focused on building shareholder value through long-term strategic investments [2] - The company operates through its subsidiary, Hampton Securities Limited, which provides family office services, wealth management, institutional services, and capital markets activities, and is regulated by the Investment Industry Regulatory Organization of Canada [2] - Hampton also offers investment banking services, including capital raises, mergers and acquisitions advisory, and assistance with listings on recognized securities exchanges in Canada [2] - The company is involved in commercial lending through its subsidiary, Oxygen Working Capital Corp., which provides financing solutions to businesses across Canada [2] - Hampton is actively seeking to diversify its revenue base through selective strategic investments in complementary and non-core sectors, leveraging the expertise of its Board of Directors and management team [2]
NCS Multistage Holdings, Inc. Schedules Fourth Quarter 2025 Earnings Release and Conference Call
Globenewswire· 2026-02-25 22:42
Company Overview - NCS Multistage Holdings, Inc. is a leading provider of highly engineered products and support services for optimizing oil and natural gas well construction, completions, and field development strategies [3] - The company primarily serves exploration and production companies for onshore and offshore wells, especially those drilled with horizontal laterals in both unconventional and conventional formations [3] - NCS's products and services are utilized in oil and natural gas basins across North America and selected international markets, including the North Sea, the Middle East, and Argentina [3] - The company's common stock is traded on the Nasdaq Capital Market under the symbol "NCSM" [3] Upcoming Events - NCS will host a conference call to discuss its fourth quarter 2025 results on March 5, 2026, at 7:30 a.m. Central Time [1] - The earnings release for the fourth quarter 2025 will be issued the evening prior to the conference call [1] - The conference call will be available via a live audio webcast, and participants can register to ask questions or join as listeners [2] - A replay of the conference call will be available in the Investors section of the company's website shortly after the call and will remain accessible for approximately seven days [2]
Carriage Services Announces Strong Fourth Quarter and Full Year 2025 Results and Issues 2026 Guidance
Globenewswire· 2026-02-25 22:31
Core Insights - Carriage Services, Inc. reported strong financial performance for Q4 and the full year 2025, with significant growth in both funeral and cemetery operations [3][4]. Financial Highlights - In Q4 2025, total funeral operating revenue increased by 9.6%, while total cemetery operating revenue grew by 18.4% [3]. - Operating income rose by 16.8%, and adjusted consolidated EBITDA increased by 11.0%, with an adjusted consolidated EBITDA margin of 30.8%, up 80 basis points year-over-year [3][4]. - For the full year 2025, GAAP diluted EPS grew nearly 55% to $3.25, and adjusted diluted EPS increased by 21% to $3.20 [6][4]. - Total revenue for the year reached $417.4 million, a 6.1% increase from 2024, driven by higher contract volumes and improved pricing discipline [4][15]. Operational Metrics - The company completed strategic acquisitions of two businesses generating over $15 million in annual revenue and divested non-core assets, resulting in a leverage ratio of 4.0x [4][6]. - Preneed cemetery sales production increased by 13.4% year-over-year, contributing to the overall revenue growth [4][6]. - The average price per preneed interment right sold was $5,643, up from $5,264 in the previous year [7]. Outlook for 2026 - The company projects total revenue between $440 million and $450 million, with adjusted consolidated EBITDA expected to be between $135 million and $140 million [10]. - Adjusted diluted EPS is forecasted to be in the range of $3.35 to $3.55, with adjusted free cash flow anticipated between $40 million and $50 million [10].
Premier Health Reports 2026 First Quarter Results
Globenewswire· 2026-02-25 22:25
Core Viewpoint - Premier Health of America Inc. has reported a significant decline in revenues and gross margin for the first quarter ended December 31, 2025, compared to the same period in 2024, while focusing on cost reduction and operational efficiency [2][3][4]. Financial Performance - Revenues for the first quarter were CAD 17.835 million, down from CAD 32.132 million in the same quarter of 2024, representing a decrease of approximately 44.4% [2]. - Gross margin decreased to CAD 2.726 million, with a gross margin percentage of 15.28%, compared to CAD 5.137 million and 16.0% in the previous year [2]. - Adjusted EBITDA fell to CAD 5, down from CAD 705,000 in the same period last year, indicating a significant decline in operational profitability [2][8]. - The net loss for the quarter was CAD 2.549 million, compared to a net loss of CAD 2.261 million in the same quarter of 2024 [2][8]. Operational Highlights - The travel nurse and northern communities services are performing well overall, except for a decline in British Columbia due to a service acquisition centralization initiative by health authorities [3]. - The company has formally discontinued its Per Diem and Transportation operations, reallocating resources to focus on Travel Nurse operations across Canada [3][4]. - The interim CEO emphasized ongoing efforts in cost reduction, debt management, and operational efficiency, with a commitment to pursuing organic growth opportunities [4]. Company Overview - Premier Health is a leading Canadian Healthtech company that provides a comprehensive range of outsourced healthcare services to governments, companies, and individuals [6]. - The company utilizes its proprietary LiPHe platform to drive digital transformation in the healthcare services sector, aiming to provide faster, more affordable, and accessible care [6].
Fitch Ratings Upgrades SiriusPoint's Operating Subsidiaries to ‘A' (Strong)
Globenewswire· 2026-02-25 22:24
Core Viewpoint - Fitch Ratings has upgraded SiriusPoint Ltd.'s ratings, reflecting strong earnings and improved financial stability, with a stable outlook [1][2]. Group 1: Rating Upgrades - SiriusPoint's Insurer Financial Strength (IFS) rating upgraded to 'A' from 'A-' [1] - Long-Term Issuer Default Rating (IDR) upgraded to 'BBB+' from 'BBB' [1] - Senior debt rating upgraded to 'BBB' from 'BBB-' [1] Group 2: Financial Performance - The upgrade is attributed to strong earnings driven by solid underwriting profitability and a reduced risk profile [2] - Key drivers include strengthened capitalization, reduced leverage, and favorable reserve development [2] - The company has shown solid underwriting results over the last three years, indicating improved risk selection [2] Group 3: Company Overview - SiriusPoint is a global underwriter of insurance and reinsurance, headquartered in Bermuda with offices in major cities [3] - The company has over $3.0 billion in total capital and holds strong financial strength ratings from multiple agencies [3] - It offers Property & Casualty and Accident & Health insurance and reinsurance globally, supported by strategic partnerships [3]
GFG Grants Stock Options and Announces Upcoming Investor Conferences
Globenewswire· 2026-02-25 22:22
Core Viewpoint - GFG Resources Inc. has granted stock options to directors, officers, employees, and senior consultants, totaling 3,530,000 common shares at an exercise price of $0.145 per share, reflecting the closing price on February 17, 2026, with a five-year term from the grant date [1][2]. Company Overview - GFG Resources Inc. is a North American precious metals exploration company focused on large-scale gold projects in tier one mining jurisdictions, operating three gold projects in the Timmins gold district of Ontario, Canada, which has produced over 70 million ounces of gold [4]. Stock Options Details - The stock options granted are subject to various vesting provisions in accordance with the Company's Stock Option Plan and applicable TSX Venture Exchange policies [2]. Upcoming Investor Conferences - GFG will participate in several investor and industry conferences, including: - March 1–4, 2026: PDAC Convention in Toronto, Canada - March 18–19, 2026: Swiss Mining Institute Investor Conference in Zurich, Switzerland - May 11–12, 2026: 121 Mining Investment Conference in London, England - May 15–16, 2026: Deutsche Goldmesse Gold Show in Frankfurt, Germany - June 9–11, 2026: Timmins Mining Expo in Timmins, Canada - June 15–16, 2026: 121 Mining Investment Conference in New York, United States [3][7].
Kneat Releases 2025 Annual Shareholder Letter Highlighting Resilience, Opportunities Presented by Artificial Intelligence
Globenewswire· 2026-02-25 22:17
Core Viewpoint - Kneat.com, inc. demonstrated strong growth and resilience in 2025 despite macroeconomic challenges, highlighting its essential role in the life sciences sector and the opportunities for future expansion [2][8]. Financial Performance - Software revenue increased by 33% in 2025, with the company achieving over $74 million in Annual Recurring Revenue (ARR) [2]. - The Net Revenue Retention (NRR) rate was 115% in 2025, although it decreased from 2024 due to deferred expansion deals and churn related to non-strategic customers [2]. Market Position and Customer Base - Kneat gained a record number of new customers in 2025, reinforcing its position as a trusted standard in the life sciences industry [7]. - The company serves some of the largest life sciences manufacturers, including 8 of the top 10 pharmaceutical manufacturers, establishing significant barriers to entry for competitors [3][4]. Product Differentiation and Innovation - Kneat's platform is designed for rigorous validation in regulated environments, ensuring data integrity and compliance, which is difficult for competitors to replicate [4]. - The introduction of AI capabilities in 2025, such as content review and natural-language process analysis, enhances the platform's functionality while maintaining compliance standards [5]. Customer Satisfaction and Recognition - Kneat achieved a G2 Satisfaction Score of 98/100, the highest in the Pharma and Biotech category, and maintained a Net Promoter Score above 70, indicating strong customer advocacy [6]. - The company received a Gold Stevie® Award for excellence in global tech support, further solidifying its reputation in the industry [6]. Future Outlook - The company is confident in its scalable business model and market opportunities, focusing on disciplined investment and improving operating efficiency to achieve cash-flow breakeven [8].
Kneat Achieves Record Revenue for Fourth Quarter and Full Year 2025
Globenewswire· 2026-02-25 22:12
Core Insights - Kneat.com, inc. has reinforced its leadership position in the life sciences sector by achieving the highest-ever number of new customer wins in 2025, alongside significant revenue growth and advancements in its technology platform [1][12]. Financial Performance - Fourth-quarter revenues increased by 24% to CAD 17.0 million, compared to CAD 13.7 million in Q4 2024 [6][7]. - Software-as-a-Service (SaaS) revenue grew by 29% to CAD 16.2 million in Q4 2025, up from CAD 12.5 million in Q4 2024 [6][7]. - For the full year 2025, total revenues rose by 29% to CAD 63.3 million, compared to CAD 48.9 million in 2024 [7]. - Annual Recurring Revenue (ARR) reached CAD 74.1 million at the end of 2025, marking a 24% increase from CAD 59.7 million at the end of 2024 [6][7]. - Kneat achieved positive Adjusted EBITDA of CAD 4.2 million in Q4 2025, compared to CAD 2.6 million in Q4 2024 [7][19]. Customer Acquisition and Satisfaction - In 2025, Kneat achieved a record year for new customer acquisitions, including nine major strategic wins, representing over 300,000 employees across various life sciences sectors [12]. - The Kneat Gx platform was recognized as the 1 Pharma and Biotech Software by G2, earning a customer satisfaction score of 98/100 [8]. Strategic Developments - Kneat entered a significant partnership with Capgemini to enhance digital validation across global manufacturing networks [12]. - The company expanded its leadership team with key appointments to strengthen its long-term vision and commitment to innovation [12]. Operational Outlook - Kneat anticipates continued growth in 2026, expecting to outpace the incremental ARR achieved in 2025, despite typical second-half seasonality [11]. - The company aims for cash-flow breakeven in 2026, supported by a solid balance sheet and operational momentum [15].
DIRTT Reports Fourth Quarter 2025 Financial Results and Provides 2026 Guidance
Globenewswire· 2026-02-25 22:08
Core Insights - DIRTT Environmental Solutions Ltd. reported financial results for Q4 and the full year 2025, showing a revenue increase and strategic developments aimed at transformation and growth [1][2][3]. Financial Performance - Q4 2025 revenue was $50.9 million, a 4% increase from $48.9 million in Q4 2024, aligning with guidance expectations [2][4]. - Gross profit for Q4 2025 was $18.6 million, representing a gross profit margin of 36.6%, up from 35.9% in Q4 2024 [5]. - The net loss after tax for Q4 2025 was $3.7 million, compared to a net income of $4.0 million in Q4 2024 [16]. - Adjusted EBITDA for Q4 2025 was $6.2 million, or 12.1% of revenue, an improvement from $5.5 million or 11.2% of revenue in Q4 2024 [17]. Strategic Developments - The company appointed Scott Robinson as Executive Chairman and Adrian Zarate as Chief Transformation Officer to drive its transformation plan [2][19]. - DIRTT entered into a financing agreement with the Business Development Bank of Canada for up to C$15 million, with C$5.5 million received to date [2][3]. - A normal course issuer bid was renewed, allowing the company to acquire up to 9,593,878 common shares [2]. Operational Insights - Sales and marketing expenses decreased to $5.4 million in Q4 2025 from $5.8 million in Q4 2024, while general and administrative expenses increased to $8.0 million from $5.1 million [6][7]. - The company recognized a one-time impairment expense of $2.3 million related to the early termination of a lease at its former manufacturing facility [13]. - DIRTT's liquidity stood at $32.1 million as of December 31, 2025, down from $39.3 million a year earlier [2][20]. Future Outlook - The company anticipates revenue for 2026 to be between $194.0 million and $209.0 million, with Adjusted EBITDA expected between $26.0 million and $31.0 million [3][25]. - The broader macroeconomic environment remains supportive, with indicators such as the Dodge Momentum Index showing positive trends [18].
Constellation Software Inc. and Topicus.Com Inc. Announce Results for Topicus.com Inc. for the Fourth Quarter and Year Ended December 31, 2025
Globenewswire· 2026-02-25 22:04
Core Insights - Topicus.com Inc. reported a total revenue of €436.8 million for Q4 2025, marking a 20% increase from €364.9 million in Q4 2024, with a full-year revenue of €1,552.3 million, also a 20% increase from €1,249.9 million in 2024 [5][7] - The net income for Q4 2025 rose to €79.4 million, a 41% increase from €56.2 million in Q4 2024, while the annual net income decreased to €70.1 million, a 53% decline from €149.5 million in 2024 [6][7] - The company experienced organic growth of 4% for both the quarterly and annual periods, with acquisitions contributing significantly to revenue growth [5][6] Financial Performance - Q4 2025 total revenue was €436.8 million, up €71.9 million from Q4 2024, while annual revenue reached €1,552.3 million, an increase of €257.4 million from 2024 [5][7] - Net income for Q4 2025 was €79.4 million, translating to €0.59 per share, compared to €56.2 million (€0.40 per share) in Q4 2024 [6][7] - For the full year, net income decreased to €70.1 million (€0.50 per share) from €149.5 million (€1.11 per share) in 2024, primarily due to a €221.7 million expense related to the investment in Asseco [6][7] Cash Flow and Investments - Cash flows from operations (CFO) increased by 35% to €107.7 million in Q4 2025, and by 19% to €412.7 million for the full year [9][27] - Free cash flow available to shareholders (FCFA2S) rose by 40% to €51.2 million in Q4 2025 and by 23% to €218.7 million for the year [10][27] - The company completed acquisitions totaling €390.4 million in 2025, including a net investment in Asseco Poland S.A. of €384.9 million [7][27] Assets and Liabilities - Total assets as of December 31, 2025, were €2,513.2 million, up from €1,535.9 million in 2024, with significant increases in cash and intangible assets [17][18] - Total liabilities increased to €1,731.4 million from €1,004.5 million in 2024, reflecting higher debt levels associated with acquisitions [18][27] - Shareholders' equity rose to €781.8 million from €531.4 million in 2024, driven by retained earnings and comprehensive income [18][23]